Messenger
KUWAIT CITY, Dec 20: Pfizer, the manufacturer of the COVID-19 vaccine, affirmed that the arrival of the COVID-19 in Kuwait is imminent, but it will soon inform Kuwait’s Ministry of Health about the final shipment and supply schedule, reports Al-Qabas daily.
Meanwhile, the Ministry of Health has placed the Moderna vaccine under observation after the US Food and Drug Administration approved the use of the vaccine.
According to reliable sources from the ministry, the ministry has been monitoring the latest developments and experiments that are being carried out on more than one vaccine around the world in order to reserve quantities of them as soon as they obtain official approvals, after procuring separate quantities previously.
COVID-19: Twenty six corps members test positive in Jigawa orientation camp
Published
Jigawa State COVID-19 taskforce committee says twenty-nine new cases have been identified in the state out of which twenty-six are corps members.
Chairman of the taskforce and Permanent Secretary, Ministry of Health Dr. Salisu Mu’azu disclosed this after a stakeholders’ meeting in Dutse.
He explained that fourteen corps members tested positive in the batch B stream I NYSC orientation camp, out of which eight are currently admitted while the remaining six have recovered and discharged.
“No fewer than eight COVID-19 patients are currently on admission at one of the isolation centres” he noted.
Market mechanism should not determine COVID-19 vaccine pricing: MP 14th December 2020
Sinovac s vaccine kept at the Bio Farma Headquarters, Bandung, West Java. ANTARA PHOTO/HO/Presidential Secretariat-Muchlis Jr/wpa/hp./pri
The government must be present in regulating the prices of COVID-19 vaccines and not leave it to market mechanism Jakarta (ANTARA) - Indonesia s House of Representatives (DPR RI) Commission VI member Mahfudz Abdurrahman urged the government to ensure that vaccine prices are not left to market mechanisms to deter rent-seeking practices in vaccine supply. The government must be present in regulating the prices of COVID-19 vaccines and not leave it to market mechanism, so that the prices of COVID-19 vaccines do not burden the public, Abdurrahman noted in a written statement here on Monday.